326 related articles for article (PubMed ID: 37712224)
1. Extracellular vesicles in acute respiratory distress syndrome: Understanding protective and harmful signaling for the development of new therapeutics.
Bavuso M; Miller N; Sill JM; Dobrian A; Colunga Biancatelli RML
Histol Histopathol; 2024 Feb; 39(2):131-144. PubMed ID: 37712224
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS.
Dutra Silva J; Su Y; Calfee CS; Delucchi KL; Weiss D; McAuley DF; O'Kane C; Krasnodembskaya AD
Eur Respir J; 2021 Jul; 58(1):. PubMed ID: 33334945
[TBL] [Abstract][Full Text] [Related]
3. Stem Cell Extracellular Vesicles as Anti-SARS-CoV-2 Immunomodulatory Therapeutics: A Systematic Review of Clinical and Preclinical Studies.
Ahmed SH; AlMoslemany MA; Witwer KW; Tehamy AG; El-Badri N
Stem Cell Rev Rep; 2024 May; 20(4):900-930. PubMed ID: 38393666
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles in acute respiratory distress syndrome: Recent developments from bench to bedside.
Quan C; Wang M; Chen H; Zhang H
Int Immunopharmacol; 2021 Nov; 100():108118. PubMed ID: 34492532
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Vesicles: A New Frontier for Research in Acute Respiratory Distress Syndrome.
Mahida RY; Matsumoto S; Matthay MA
Am J Respir Cell Mol Biol; 2020 Jul; 63(1):15-24. PubMed ID: 32109144
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential.
Esquivel-Ruiz S; González-Rodríguez P; Lorente JA; Pérez-Vizcaíno F; Herrero R; Moreno L
Front Physiol; 2021; 12():752287. PubMed ID: 34887773
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicles in the pathogenesis and treatment of acute lung injury.
Hu Q; Zhang S; Yang Y; Yao JQ; Tang WF; Lyon CJ; Hu TY; Wan MH
Mil Med Res; 2022 Nov; 9(1):61. PubMed ID: 36316787
[TBL] [Abstract][Full Text] [Related]
8. CD14-positive extracellular vesicles in bronchoalveolar lavage fluid as a new biomarker of acute respiratory distress syndrome.
Mahida RY; Price J; Lugg ST; Li H; Parekh D; Scott A; Harrison P; Matthay MA; Thickett DR
Am J Physiol Lung Cell Mol Physiol; 2022 Apr; 322(4):L617-L624. PubMed ID: 35234046
[TBL] [Abstract][Full Text] [Related]
9. Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic.
Zhuang X; Jiang Y; Yang X; Fu L; Luo L; Dong Z; Zhao J; Hei F
Front Immunol; 2023; 14():1244930. PubMed ID: 37711624
[TBL] [Abstract][Full Text] [Related]
10. Extracellular Vesicles, New Players in Sepsis and Acute Respiratory Distress Syndrome.
Jing W; Wang H; Zhan L; Yan W
Front Cell Infect Microbiol; 2022; 12():853840. PubMed ID: 35463634
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis.
Su Y; Silva JD; Doherty D; Simpson DA; Weiss DJ; Rolandsson-Enes S; McAuley DF; O'Kane CM; Brazil DP; Krasnodembskaya AD
Thorax; 2023 Jun; 78(6):617-630. PubMed ID: 35948417
[TBL] [Abstract][Full Text] [Related]
12. Extracellular Vesicles Derived from Mesenchymal Stem Cells: A Potential Biodrug for Acute Respiratory Distress Syndrome Treatment.
Sun H; Zhang T; Gao J
BioDrugs; 2022 Nov; 36(6):701-715. PubMed ID: 36087245
[TBL] [Abstract][Full Text] [Related]
13. Lung epithelial cell-derived extracellular vesicles activate macrophage-mediated inflammatory responses via ROCK1 pathway.
Moon HG; Cao Y; Yang J; Lee JH; Choi HS; Jin Y
Cell Death Dis; 2015 Dec; 6(12):e2016. PubMed ID: 26658190
[TBL] [Abstract][Full Text] [Related]
14. Circulating extracellular vesicles are associated with the clinical outcomes of sepsis.
Li P; Wu Y; Goodwin AJ; Wolf B; Halushka PV; Wang H; Zingarelli B; Fan H
Front Immunol; 2023; 14():1150564. PubMed ID: 37180111
[TBL] [Abstract][Full Text] [Related]
15. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial.
Zarrabi M; Shahrbaf MA; Nouri M; Shekari F; Hosseini SE; Hashemian SR; Aliannejad R; Jamaati H; Khavandgar N; Alemi H; Madani H; Nazari A; Amini A; Hassani SN; Abbasi F; Jarooghi N; Fallah N; Taghiyar L; Ganjibakhsh M; Hajizadeh-Saffar E; Vosough M; Baharvand H
Stem Cell Res Ther; 2023 Jun; 14(1):169. PubMed ID: 37365605
[TBL] [Abstract][Full Text] [Related]
16. Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome.
Meidert AS; Hermann S; Brandes F; Kirchner B; Buschmann D; Billaud JN; Klein M; Lindemann A; Aue E; Schelling G; Pfaffl MW; Reithmair M
Front Immunol; 2021; 12():784028. PubMed ID: 34956213
[TBL] [Abstract][Full Text] [Related]
17. Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives.
Su Y; Guo H; Liu Q
J Leukoc Biol; 2021 Jul; 110(1):27-38. PubMed ID: 33955590
[TBL] [Abstract][Full Text] [Related]
18. Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS).
Huang Q; Le Y; Li S; Bian Y
Respir Res; 2024 Jan; 25(1):30. PubMed ID: 38218783
[TBL] [Abstract][Full Text] [Related]
19. Role of extracellular vesicles in severe pneumonia and sepsis.
Hwang W; Shimizu M; Lee JW
Expert Opin Biol Ther; 2022 Jun; 22(6):747-762. PubMed ID: 35418256
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
